Skip to content

Prospective Study to Validate the Clinical Accuracy of Norbert Device to Measure Body Temperature

Prospective Study to Validate the Clinical Accuracy of Norbert Device to Measure Body Temperature

Status
Withdrawn
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05640310
Enrollment
0
Registered
2022-12-07
Start date
2023-03-31
Completion date
2023-07-31
Last updated
2023-08-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Febrile Illness, Healthy

Keywords

medical device, validation, febrile, thermometer, body temperature, Norbert Device, Norbert Health

Brief summary

The study will evaluate the clinical bias and clinical repeatability of measuring body temperature using the Norbert Device (ND).

Detailed description

The study design is based on the ISO 80601-2-56, Clause 201.102 for adjusted mode clinical thermometers. The study is designed to be a non-randomized, non-blinded single arm design to evaluate the clinical accuracy of the ND's temperature measurement compared to a standard FDA 510(k)-cleared reference clinical thermometer (RCT).

Interventions

The Norbert Device (ND) is a contactless, noninvasive device that provides measurements of body temperature, oxygen saturation (SpO2), and pulse rate.

Sponsors

Northwell Health
CollaboratorOTHER
Norbert Health
Lead SponsorINDUSTRY

Study design

Observational model
OTHER
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
22 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Male or female subjects over 22 years of age * Ability to provide signed informed consent, and/or have a legally authorized representative (LAR) willing to provide informed consent on behalf of the subject * ESI score of 3-5

Exclusion criteria

* Use of medications known to affect body temperature (for example, antipyretics, barbiturates, thyroid preparations, antipsychotics, etc.) within 3 hours of the study procedure * Recent immunization within seven days of the study procedure * Pregnancy * ESI score of 1-2

Design outcomes

Primary

MeasureTime frameDescription
Clinical BiasUp to 1 hourClinical Bias will be evaluated by comparing the first recorded measurement using ND with the corresponding measurement recorded by the RCT. The bias is calculated per IEC 80601-2-56, Clause 201.103.3.
Limits of AgreementUp to 1 hourLimits of Agreement (LOA) will be calculated using all three measurements by the ND and the corresponding measurements by the RCT. The LOA is calculated per IEC 80601-2-56, Clause 201.103.4.
Clinical RepeatabilityUp to 1 hourClinical Repeatability is calculated by a pooled standard deviation of the triplicate measurements over the entire population of subjects. The method to calculate Clinical Repeatability is per IEC 80601-2-56, Clause 201.102.5.

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026